Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesAdheris Health Limited

Adheris Health Limited

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
0.013 AUD 0.00(0%)
Last update at 2026-11-12T05:10:00Z
VOLUME
589211
Market Cap
8.93M

Momentum Score

…

Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in the United States. The company offers THRiV, a patient engagement platform, which transforms the patient experience by harnessing predictive modeling and precision segmentation. The company was formerly known as MedAdvisor Limited and changed its anme to Adheris Health Limited in November 2025. The company was incorporated in 2010 and is based in Woburn, Massachusetts.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.03
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Adheris Health Limited provides medication adherence and patient engagement services and technologies to pharmacies, healthcare providers and payers. Long-term growth may be supported by rising chronic disease prevalence, aging populations and increased adoption of digital health tools. The company's B2B model appears positioned to generate recurring revenue and expand service reach across care pathways.

Important risks include competitive pressure from larger digital health and pharmacy technology firms, exposure to healthcare regulatory and reimbursement changes across markets, data privacy and system-integration challenges, and execution risk in commercial expansion.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
33.96M
Revenue Per Share
0.05
Gross Profit TTM
-2.81M
Debt / Equity
-0.05
ROE
-177.91%
Net Debt
-9.40M
ROCE
695.28%
Diluted EPS TTM
-0.03

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -20.34M -63.31M -2.21M -10.52M -17.73M
Net income -19.97M -60.21M 0.79M -11.31M -17.35M
Selling general administrative - 39.65M 45.86M 44.73M 32.24M
Selling and marketing expenses - - - - 2.66M
Gross profit -3.49M 32.92M 53.52M 59.41M 34.99M
Ebit -16.67M - - - -16.19M
Ebitda -16.53M - - - -11.29M
Depreciation and amortization 0.14M - - - 4.90M
Operating income -16.67M -63.31M -2.21M -10.57M -16.19M
Other operating expenses 50.63M - - - 83.94M
Interest expense 3.70M 2.80M 1.77M 2.13M 1.54M
Tax provision - 0.01M 0.13M 0.79M -
Extraordinary items - 3.11M 3.13M - -
Income tax expense -0.37M - - - -0.24M
Total revenue 33.96M 62.99M 98.40M 97.96M 67.75M
Total operating expenses 13.18M 126.31M 100.61M 108.53M 51.18M
Cost of revenue 37.45M 30.08M 44.89M 38.55M 32.76M
Total other income expense net -3.67M - - - -1.54M
Net income applicable to common shares - -60.21M 0.79M -11.31M -
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 16.59M 39.84M 98.78M 95.91M 78.57M
Intangible assets - 0.00M 18.51M 19.80M 18.96M
Other current assets 0.86M 19.41M 0.12M 0.12M 1.85M
Total liab 19.03M 38.79M 47.20M 47.45M 51.40M
Total stockholder equity -2.44M 1.05M 51.58M 48.46M 34.55M
Other current liab 4.90M - - - 23.81M
Common stock 125.03M 123.67M 116.55M 115.41M 91.81M
Retained earnings -136.61M -124.79M -66.22M -68.45M -61.58M
Good will - 0.00M 46.34M 46.61M 37.38M
Other assets - 0.02M 0.02M 0.02M -
Cash 9.53M 10.30M 15.58M 14.20M 7.58M
Total current liabilities 18.99M 20.23M 45.67M 33.17M 42.77M
Current deferred revenue 5.82M - - - 7.51M
Net debt -9.40M - - - 5.84M
Short term debt 0.09M 0.00M 0.00M 0.00M 5.45M
Short long term debt total 0.13M - - - 13.41M
Other stockholder equity - 2.17M 1.26M 1.50M -
Property plant equipment - 0.33M 0.44M 1.37M -
Total current assets 14.39M 39.50M 32.51M 28.11M 18.48M
Net receivables 3.99M 7.82M 13.02M 8.94M 9.05M
Long term debt - 17.17M 0.00M 12.05M -
Accounts payable 8.17M - - - 6.00M
Accumulated other comprehensive income 9.14M - - - 4.32M
Non currrent assets other 0.06M - - - 0.14M
Non current assets total 2.20M - - - 60.10M
Long term debt total - 17.31M 0.00M 12.31M -
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total cashflows from investing activities 9.92M -2.18M -2.80M -3.23M -0.29M
Total cash from financing activities 0.28M 11.34M -0.83M 12.42M 1.86M
Net income -19.97M - - -11.31M -17.35M
Change in cash -0.77M -5.27M 1.38M 6.62M 0.43M
Begin period cash flow 10.30M - - 7.58M 7.15M
End period cash flow 9.53M - - 14.20M 7.58M
Total cash from operating activities -10.27M -14.37M 5.19M -1.45M -0.24M
Depreciation 0.14M - - 5.35M 4.90M
Other cashflows from investing activities - -1.09M -0.96M -4.47M -
Change to account receivables 4.73M - - -1.78M 3.41M
Sale purchase of stock - 7.24M 0.00M -0.95M -0.05M
Other cashflows from financing activities -0.09M -0.52M 0.00M -1.23M -1.52M
Capital expenditures 0.00M 1.09M 1.83M 0.18M 0.31M
Change in working capital 4.71M 0.13M 0.15M 1.93M 10.99M
Other non cash items 4.84M - - 2.57M 1.22M
Free cash flow -10.27M - - -1.63M -0.55M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AHE
Adheris Health Limited		 -
-%		 0.01 - 8.00 0.26 0.93 0.01 64.03
PME
Pro Medicus Ltd		 -4.52
2.18%		 202.79 81.98 106.38 83.13 43.70 74.38 95.34
4DX
4DMEDICAL Ltd		 -0.06
2.53%		 2.31 - - 205.57 8.53 170.03 -7.29
CGS
Cogstate Ltd		 0.12
3.30%		 3.76 33.80 27.86 9.59 6.95 6.35 19.27
AYA
ARTRYA Ltd		 -0.14
3.91%		 3.44 - - 20505.14 7.00 16927.51 0.33

Profile*

Adheris Health Limited

Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in the United States. The company offers THRiV, a patient engagement platform, which transforms the patient experience by harnessing predictive modeling and precision segmentation. The company was formerly known as MedAdvisor Limited and changed its anme to Adheris Health Limited in November 2025. The company was incorporated in 2010 and is based in Woburn, Massachusetts.

100 TradeCenter, Woburn, MA, United States, 01801

781 425 6611

https://www.medadvisorsolutions.com

Name Title Year Born
Mr. John Ciccio CEO, MD & Director 1973
Mr. Sean Slattery CFO, Company Secretary & Director NA
Mr. Vinod Subramanian Chief Operating Officer NA
Mr. Craig Schnuriger Chief Technology Officer NA
Ms. Sarah Sweeney Senior Vice President of Global Marketing NA
Mr. James M. Rotsart R.Ph. Executive VP of US & Client Relations NA
Mr. Brian Peterson President of US NA
Ms. Gillian Maria Nairn AGIA, B.A., L.L.B., L.L.M., MAICD Company Secretary NA
Mr. John Ciccio CEO, MD & Director 1974
Mr. John Ciccio CEO, MD & Director 1981

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…